BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7115451)

  • 21. [Tiopronin in 69 cases of rheumatoid polyarthritis treated earlier with D-penicillamine].
    Sigaud M; Maugars Y; Maisonneuve H; Prost A
    Rev Rhum Mal Osteoartic; 1988 Apr; 55(6):467-71. PubMed ID: 3134689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiopronine therapy in rheumatoid arthritis.
    Pasero G; Ciompi ML
    Arthritis Rheum; 1979 Jul; 22(7):803-4. PubMed ID: 454510
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sulfhydryl-based treatment of rheumatoid arthritis (penicillamine, pyrithioxin, thiopronine)].
    Camus JP; Prier A; Cassou B; Bergevin H
    Rev Prat; 1980 Apr; 30(23):1517-8, 1521-3. PubMed ID: 7384712
    [No Abstract]   [Full Text] [Related]  

  • 24. Mercaptopropionylglycine: a progress in cystine stone therapy.
    Hautmann R; Terhorst B; Stuhlsatz HW; Lutzeyer W
    J Urol; 1977 May; 117(5):628-30. PubMed ID: 870714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis.
    Hansen TM; Kryger P; Elling H; Haar D; Kreutzfeldt M; Ingeman-Nielsen MW; Olsson AT; Pedersen C; Rahbek A; Tvede N
    BMJ; 1990 Aug; 301(6746):268-70. PubMed ID: 2202458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical efficacy and adverse effects of tiopronin in rheumatoid arthritis. Report of a follow-up in 50 patients.
    Ambanelli U; Manganelli P; Ferraccioli GF
    Z Rheumatol; 1982; 41(5):235-9. PubMed ID: 7158085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proceedings: Penicillamine or gold for rheumatoid arthritis? Multicentre trial using 'blind' observers. The first six months.
    Huskisson EC; Gibson TJ; Balme HW; Berry H; Burry HC; Grahame R; Hart FD; Henderson DR; Wojtulewski JA
    Ann Rheum Dis; 1974 Jul; 33(4):399. PubMed ID: 4606941
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic effects of tiopronin on chronic hepatitis: a double-blind clinical study.
    Ichida F; Shibasaki K; Takino T; Suzuki H; Fujisawa K; Inoue K; Hirayama C; Kaito I; Hirasawa T; Kameda H; Inoue J; Satoh G; Kosaka Y; Yamamoto S; Nagashima H; Tsuji T; Ohta Y; Okada J
    J Int Med Res; 1982; 10(5):325-32. PubMed ID: 6128281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tiopronine and rheumatoid polyarthritis].
    Amor B; Mery C; de Gery A; Zizi M
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):39-43. PubMed ID: 3704511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A biochemical comparison of alclofenac and D-penicillamine in rheumatoid arthritis.
    Bird HA; Dixon JS; Pickup ME; Lee MR; Wright V
    Ann Rheum Dis; 1980 Jun; 39(3):281-4. PubMed ID: 6106453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alclofenac and D-penicillamine. Comparative trial in rheumatoid arthritis.
    Berry H; Fernandes L; Ford-Hutchinson AW; Evans SJ; Hamilton EB
    Ann Rheum Dis; 1978 Feb; 37(1):93-7. PubMed ID: 24426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized, double blind, multicenter study.
    van Rijthoven AW; Dijkmans BA; Thè HS; Meijers KA; Montnor-Beckers ZL; Moolenburgh JD; Boers M; Cats A
    J Rheumatol; 1991 Jun; 18(6):815-20. PubMed ID: 1895262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of alclofenac treatment on acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
    Maddock J; Rees P; Holly F; Aylward M
    Curr Med Res Opin; 1975; 3(5):286-97. PubMed ID: 241598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does second-line therapy affect the radiological progression of rheumatoid arthritis?
    Pullar T; Hunter JA; Capell HA
    Ann Rheum Dis; 1984 Feb; 43(1):18-23. PubMed ID: 6421253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarthritic drugs containing thiol groups scavenge hypochlorite and inhibit its formation by myeloperoxidase from human leukocytes. A therapeutic mechanism of these drugs in rheumatoid arthritis?
    Cuperus RA; Muijsers AO; Wever R
    Arthritis Rheum; 1985 Nov; 28(11):1228-33. PubMed ID: 2998407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled trial of D-penicillamine in rheumatoid arthritis. Dose effect and the role of zinc.
    Mery C; Delrieu F; Ghozlan R; Saporta L; Simon F; Amor B; Menkes CJ; Delbarre F
    Scand J Rheumatol; 1976; 5(4):241-7. PubMed ID: 795022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
    Leonard PA; Bienz SR; Clegg DO; Ward JR
    J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Auranofin or D-penicillamine in the treatment of rheumatoid arthritis.
    Hochberg MC
    Ann Intern Med; 1986 Oct; 105(4):528-35. PubMed ID: 3092712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D-penicillamine in early rheumatoid arthritis: experience from a 2-year double blind placebo controlled study.
    Eberhardt K; Rydgren L; Fex E; Svensson B; Wollheim FA
    Clin Exp Rheumatol; 1996; 14(6):625-31. PubMed ID: 8978957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penicillamine for treatment of rheumatoid arthritis.
    Gordon MH; Ehrlich GE
    JAMA; 1974 Sep; 229(10):1342-3. PubMed ID: 4604882
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.